[1]
M. P. Barbosa et al., “INCIDENCE, SEVERITY, AND DISCONTINUATION DUE TO GASTROINTESTINAL ADVERSE EVENTS ASSOCIATED WITH GLP-1 RECEPTOR AGONISTS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW”, REASE, vol. 12, no. 8, pp. 1–10, Aug. 2026, doi: 10.51891/rease.v12i8.29492.